The identification of targets in cancer treatment has become a cornerstone of precision oncology, aiming to develop therapies that specifically target cancer cells while sparing normal tissues. The concept of targets in cancer refers to protein molecules or pathways that play crucial roles in the growth and survival of cancer cells. By understanding and exploiting these targets, researchers and clinicians can design treatments that are more effective and have fewer side effects than traditional therapies. The co-occurrence of targets and cancer concepts refers to the interplay between various molecular targets and the characteristics of different cancers. Understanding these relationships is crucial for developing targeted therapies and improving patient outcomes.